Epredia: now a part of SciMed (Asia)

Epredia: now a part of SciMed (Asia)

We are pleased to announce that all the product range of Epredia in Singapore is now managed by SciMed (Asia) since July 1st, 2021.

About SciMed (Asia)

Located in Singapore, SciMed (Asia) Pte Ltd is an established and leading provider of products and services for life science market. SciMed is major distributor of PHC group’s life science product for around 30 years and has become a consolidated company of PHC Holdings on July 1st, 2020. Now Epredia and SciMed (Asia) is within the PHC Group portfolio.

About Epredia

Epredia was established in July 2019 through an acquisition by PHC Group from Thermo Fisher Scientific. Powered by trusted brands such as Shandon, Microm, Menzel Gläser and Richard-Allan Scientific, Epredia has a wide breadth of solutions that have and will continue to transform the anatomical pathology market.

They are a global precision cancer diagnostics company working to improve patient outcomes by providing groundbreaking technologies. Since their humble beginnings in 1937, every product developed has been impacted by generations of employees who are committed to improving lives by enabling pathologists through enhancing precision cancer diagnostics.

The Integration of Epredia

The addition of Epredia’s product lines to complement SciMed existing product range will allow us to provide an even greater product and service offering, resulting in increased value for all our customers.
We are very excited about the opportunities that this agreement will present for our valued customer.

We appreciate your continued support to PHCHD, Epredia and SciMed (Asia).